Parametric Portfolio Associates’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $677K | Buy |
27,888
+273
| +1% | +$6.63K | ﹤0.01% | 2950 |
|
|
2021
Q4 | $889K | Buy |
27,615
+673
| +2% | +$21.7K | ﹤0.01% | 2830 |
|
|
2021
Q3 | $1.2M | Buy |
26,942
+1,297
| +5% | +$58K | ﹤0.01% | 2715 |
|
|
2021
Q2 | $970K | Buy |
25,645
+3,525
| +16% | +$133K | ﹤0.01% | 2781 |
|
|
2021
Q1 | $818K | Buy |
22,120
+7,916
| +56% | +$293K | ﹤0.01% | 3257 |
|
|
2020
Q4 | $471K | Buy |
+14,204
| New | +$471K | ﹤0.01% | 3411 |
|